Abstract
Aims To examine inequalities related to dual sexual- and ethnic-identities in risk for health, wellbeing, and health-related behaviours in a nationally representative sample of adolescents.
Methods 9,789 adolescents (51% female) aged 17 years from the UK-wide Millennium Cohort Study, with data on self-identified sexual- and ethnic-identities. Adolescents were grouped into White-Heterosexual, White sexual minority (White-SM), ethnic minority (EM)-heterosexual, and ethnic- and sexual minority (EM-SM).
Mental health (e.g., self-reported psychological distress, doctor-diagnosed depression, attempted suicide, victimisation), general health (self-rated health, chronic illness, BMI) and a range of health-related behaviours (e.g., smoking, substance use) were assessed by questionnaires. Associations between dual identities and outcomes were analysed using logistic and linear regression (adjusted for sex and parental income).
Results Sexual minorities (White:18% and ethnic minority:3%) had increased odds for mental ill-health and attempted suicide, with higher odds in White-SM than EM-SM. Compared to White-heterosexuals, White-SM and EM-SM had higher odds for psychological distress (OR 3.47/2.24 for White-SM/EM-SM respectively), and emotional problems (OR 3.17/1.65). White-SM and EM-SM had higher odds for attempted suicide (OR 2.78/2.02), self-harm (OR 3.06/1.52), and poor sleep quality (OR 1.88/1.67). In contrast, White-Heterosexual and White-SM groups had similarly high proportions reporting risky behaviours except for drug use (OR 1.34) and risky sex (OR 1.40) more common in White-SM individuals. EM-Heterosexuals and EM-SM individuals had decreased odds for health-related behaviours.
Conclusions Sexual minorities (White and EM) had substantially worse mental health compared to their heterosexual peers. Adverse health-related behaviours were more common in White sexual minority individuals. Further investigation into potentially different mechanisms leading to adverse health in White-SM and EM-SM individuals is needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partly funded by the UCL Health of the Public Small Grants Scheme 2020. Amal Khanolkar was also supported by grants from the Wellcome Trust (ISSF3/H17RCO/NG1) and MRC (MC_UU_00019/3).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for the MCS study was obtained from the National Research Ethics Service Committee London Central (reference 13/LO/1786). All data are anonymised and available to researchers via the UK Data Service. Cohort members ≥16 years provided verbal consent to take part in the overall assessment, and each survey element.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data from the Millennium Cohort Study are anonymised and available to registered researchers via the UK Data Service.